Nevertheless, the safety of supraphysiological oxygen suppletion is unproven. Randomised studies with a variety of oxygen targets and inclusion of high-risk patients are needed to identify optimal oxygen targets during and after cardiac surgery.
INTRODUCTION
During and after cardiac surgery with cardiopulmonary bypass, high concentrations of oxygen are routinely administered, with the intention of preventing cellular hypoxia 1 . Oxygen delivery to the tissues is threatened during bypass due to increased microcirculatory heterogeneity with low-and high-flow capillaries 2 . The augmented oxygen diffusion distance may impair oxygen delivery and organ function. Other factors that may reduce oxygen delivery to tissues include: hypothermia; fluid shift; myocardial dysfunction; blood loss; anaemia; and transfusion 3 . With this in mind, it may be intuitively correct to maintain a partial arterial oxygen pressure (P a O 2 ) clearly above physiological values (mostly defined as 10-13.3 kPa), to increase the oxygen gradient between capillaries and tissue and reduce the risk of cellular hypoxia. In addition, at key points during general anaesthesia, it is common practice to administer 100% oxygen to prevent hypoxaemia 4 .
However, 'too much' oxygen is not necessarily the best solution to 'not enough' oxygen 4 . Dissolved oxygen does not greatly contribute to oxygen transport capacity. Hyperoxia may cause vasoconstriction and increase microcirculatory heterogeneity, thereby compromising perfusion and, hence, actual oxygen delivery [5] [6] [7] . Also, hyperoxia can increase oxidative stress 8 and fuel the systemic inflammatory response syndrome, a major cause of bypass-associated organ injury. In a wide range of conditions, such as ischaemic heart disease, stroke and after cardiac arrest, hyperoxia is associated with increased morbidity and mortality 9 .
On the other hand, analysis of a number of published studies and adjustment for confounding factors may abolish the excess mortality and beneficial effects of hyperoxia they originally suggested. The vasoconstrictive stimulus of short-term exposure to hyperoxia before sustained ischaemia may act as a preconditioner, with attenuation of ischaemia-reperfusion injury 10, 11 .
In addition, hyperoxia-induced vasoconstriction may counteract systemic inflammation-induced vasoplegia, and reduce vasopressor requirements.
Furthermore, hyperoxia may lower damage by gas microemboli by denitrogenation 12 , and reduce postoperative infections 13 . Interestingly, in a recent study of patients after cardiac arrest, severe hyperoxia (P a O 2 >40 kPa) was associated with decreased survival, but moderate hyperoxia (P a O 2 13.3-40 kPa)
with improved Sequential Organ Failure Assessment score after 24h 14 . Current guidelines do not specify oxygen targets during and after bypass 15 . Over the years, several clinical studies have addressed the effects of hyperoxia in patients undergoing bypass, although the number of both studies and included patients are small. In this review, we summarise the current knowledge about hyperoxia during bypass-assisted cardiac surgery, emphasising cardiovascular performance. We elaborate on the molecular and pathophysiological mechanisms and summarise the results of all the clinical studies investigating hyperoxia in cardiac surgical patients. Hyperoxia may also induce lung injury 16 , especially in combination with bypass 17, 18 , but this is beyond the scope of this review.
METHODS
We conducted a systematic search of both pre-clinical and clinical studies published between 1960 and March 2015 in Medline and Embase to identify all articles addressing the effect of hyperoxia before, during and/or after all bypass-assisted cardiac surgical procedures, such as coronary artery bypass graft surgery, cardiac valve replacement or repair, and combined surgery.
Search terms were used in every possible spelling, as synonyms, acronyms, key or text words, and these groups were combined with an 'AND' operator. Two investigators (A.M.E.S. de Man and B.S.) independently performed the data extraction. The references in the reviewed articles were manually scanned for other published articles.
RESULTS

Molecular mechanisms
Inflammation and oxidative stress play a pivotal role in the effects of hyperoxia, but are also independently induced by bypass. The two are interrelated:
oxidative stress is part of the inflammatory response; and there is reciprocal amplification (Figure 1 ). Cardiopulmonary bypass induces biomaterial-dependent and -independent systemic inflammation. Biomaterial dependent inflammation is caused by the exposure of blood to artificial surfaces, and changes such as conversion into a continuous flow pattern during bypass.
Biomaterial-independent inflammation is caused by: anaesthesia; surgical trauma; cardioplegia; ischaemia-reperfusion; release of endotoxin; transfusion; and changes in body temperature ( Figure 1 ). These factors initiate a 
Cardiopulmonary bypass surgery
Pathophysiology of cardiovascular effects
Increased oxidative stress and inflammation can substantially affect cardiovascular performance. Preclinical experiments (Table 1 ) and studies in healthy volunteers and cardiovascular compromised patients (Table 2) suggest several pathophysiological mechanisms for harm. Figure 2 illustrates the potential underlying mechanisms. Due to vasoconstriction, blood pressure increases, inducing cardiac parasympathetic activation and arterial-cardiac baroreflex function. This leads to a decrease in heart rate and stroke volume 49 , thereby reducing cardiac output 48 .
Vasoconstriction of coronary vessels can decrease myocardial oxygen delivery and contribute to increased susceptibility to ischaemia, as well as reduced myocardial contractility 44, 58 . A systematic review of patients with cardiac disease showed that hyperoxia reduced coronary blood flow by 8-29%
(six studies), and myocardial oxygen consumption by 15-27% (three studies).
The diameter of the large conduit arteries remained equal, suggesting that vasoconstriction mainly occurred at a microvascular level 57,58 . Myocardial function also responds to changes in coronary flow. In dogs with cardiac ischaemia, 100% oxygen reduced coronary blood flow by constriction with reduced oxygen delivery, oxygen consumption and contractility of the ischaemic area 44 . Hyperoxia can also aggravate ischaemia/reperfusion injury of the myocardium and augment myocardial stunning 8, [73] [74] [75] [76] . Major harm occurs after ischaemia during reperfusion, with a crucial role for oxidative stress. Reperfusion of ischaemic tissues causes microvascular injury with endothelial production of reactive oxygen species, reduced nitric oxide production and increased 
Clinical trials in cardiac surgery
To what extent these potential adverse effects of hyperoxia translate into clinical effects during and after cardiac surgery have been investigated in nine clinical studies (Table 3) : five randomised controlled trials; two uncontrolled interventions; and two retrospective studies. In these studies, patients
with poor left ventricular function and valvular or combined surgery were frequently excluded. Patients were exposed to different oxygen regimens.
The randomised controlled trials investigated the following phases:
• before cardioplegia, F I O 2 >0.96 vs 0.4 for 120 and 60 min, respectively 81, 82 • during the entire bypass period, F I O 2 0.4-0.6 during rewarming vs. Because of the paucity of clinical data, we included both retrospective studies in Table 3 , but the outcome measures in these studies may be substantially affected by confounding by indication. In the large retrospective study, there was no association between hyperoxia and hospital mortality compared with normoxia. There was a small but statistically significant increase in ICU and hospital length of stay for the hyperoxic patients (1.9 vs 1.8 and 10.0 vs 9.9 days, respectively, both P<0.05) 85 . In the small retrospective study, ICU stay and mechanical ventilation time 84 tended to be slightly (10 and 2 h, respectively), but non-significantly longer in the hyperoxic groups. One study specifically addressed the risk of hypoxia 80 . Reduction of oxygen administration during cardiac surgery down to an F I O 2 of 0.35 did not cause hypoxic episodes. Even in the lower oxygen groups, patients were frequently hyperoxic (30% patients had P a O 2 >24 kPa).
Cardiovascular function
Of six studies, four suggested impaired cardiovascular function with higher oxygen targets, while two studies showed no difference ( In one study, hyperoxia aggravated microcirculatory perfusion heterogeneity 83 . Assessment of tissue oxygenation by an oxygen microelectrode in the anterior tibial muscle of patients alternately exposed to normoxaemia and hyperoxaemia during surgery showed increased heterogeneity of distribution of tissue oxygen during hyperoxaemia. This occurred especially after bypass, resulting in even lower surface oxygen tensions in the hyperoxic vs.
normoxic group: 0.8 vs 1.7 kPa (Table 3) 83 .
Animal studies suggest that hyperoxia has favourable effects on myocardial ischaemic injury through a preconditioning effect on cardiac muscle 86, 87 .
A similar study in humans, exposing patients to hyperoxia (F I O 2 >0.96) for 130
and 60 min before coronary artery bypass grafting, had no effect on the cardiac enzymes creatine kinase MB (CK-MB) and troponin I 81, 82 . However, hyperoxia applied during cardiac surgery, during reperfusion 8 or the entire bypass period 18 increased ischaemia-reperfusion injury as estimated by troponin-T Values are presented as mean (standard deviation) or median (interquartile range). Abbreviations: RCT, randomized controlled trial; CABG, coronary artery bypass graft; CI, cardiac index; CPB, cardiopulmonary bypass; CK, creatine kinase; NS, not significant and exact P-value not reported; ND, no difference; AVR, aortic valve replacement; ASD, atrial septal defect. Symbols: *, no further specification of type of cardiac surgery. Values are presented as mean (standard deviation) or median (interquartile range). Abbreviations: RCT, randomized controlled trial; CABG, coronary artery bypass graft; CI, cardiac index; CPB, cardiopulmonary bypass; CK, creatine kinase; NS, not significant and exact P-value not reported; ND, no difference; AVR, aortic valve replacement; ASD, atrial septal defect. Symbols: *, no further specification of type of cardiac surgery.
and creatine kinase 18 (Table 3) .
Lactate levels, used as a marker for tissue perfusion, were equal during different oxygen regimens 18, 80, 81 . Just one (retrospective) study reported postoperative creatinine levels, and did not find differences between hyperoxic and normoxic patients 84 .
Inflammation and oxidative stress
In the nine clinical studies, underlying mechanisms were not well explored.
Only two clinical cardiac surgical trials studied the effects of hyperoxia on the inflammatory and oxidative response (Table 3) . Normoxic bypass (19 kPa) lowered inflammation compared with hyperoxic cardiopulmonary bypass (53 kPa), as estimated by levels of polymorphonuclear leucocyte elastase (377 vs 171 ng/ml , P<0.001) 18 .
Lower oxygen targets effectively reduced oxidative stress as evidenced by a decrease of malonaldehyde levels by 18-41% 8,18 and 40% higher antioxidant levels 18 .
Gas microemboli
None of the clinical studies reported the effect of hyperoxia on development of gas microemboli. Hyperoxia can reduce emboli by denitrogenation, as gas emboli containing 80% nitrogen survive approximately ten times longer than emboli consisting of oxygen 12 , as shown by transcranial Doppler ultrasound 88 . An effect on neurological outcome was not reported. In a large (n=1018), but retrospective, trial, there was no difference between hyperoxic and normoxic patients in neurocognitive function. Gas microemboli were not investigated in this study 89 .
Gas microemboli mostly occur during open procedures such as valve replacement (incidence 1.5-10%) 90 , where they are generated by cavitation in areas of turbulent flow, by injection of solutions into the circuit or by entrainment of gas from both cannulation sites. Improvement of the components of the bypass circuit has substantially diminished the burden of gas microemboli 91 . As most of the aforementioned clinical trials excluded patients undergoing valve surgery, the clinical impact of hyperoxia on gas microemboli cannot be determined based on the available literature about different oxygen levels in cardiac surgical patients.
Postoperative infections
None of the nine clinical trials addressed the effect of hyperoxia on postoperative infections in cardiac surgical patients. Studies in colorectal surgery or obstetric surgery 92-97 yielded inconsistent results. A recent meta-analysis concluded that perioperative high inspired oxygen therapy was not beneficial for the prevention of surgical site infection 98 .
Theoretically, increased reactive oxygen species production could improve oxidative killing by neutrophils, which could be beneficial. However, this is in contrast with a recent study in rats undergoing caecal ligation and puncture and treated by hyperoxia, which showed a greater number of infected samples in the hyperoxic group 36 .
Safety of lower oxygen targets
Reduction of oxygen administration during cardiac surgery to an F I O 2 of 35%
did not result in hypoxic episodes or an increase in lactate levels 80 . None of the studies demonstrated worse outcomes for lower oxygen targets, suggesting that the margin of safety and error seemed large enough. Of note, the lower oxygen targets were still quite high (up to 33 kPa) compared with physiological oxygen values, and even in the lower oxygen groups hyperoxia frequently occurred. The optimal oxygen range might even be more close to physiological values (10-13.3 kPa) than has been investigated to date. with allopurinol compared with low-risk patients 104 .
Antioxidative agents
CONCLUSION
The present review suggests that hyperoxia may compromise cardiovascular performance in cardiac surgical patients, mainly due to increased oxidative Therefore, especially in cardiovascularly compromised patients, the safety of supraphysiologic oxygen levels is unproven. Current evidence is insufficient to specify optimal oxygen targets. Randomised studies aiming for more physiological oxygen levels and including high-risk patients are needed to identify optimal oxygen targets during and after cardiac surgery. 
